SIncalide (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the SIncalide drug offered from AnazaoHealth Corporation. This Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Sincalide
SUBSTANCE NAME: SINCALIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00


SIncalide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSIncalide from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 3(ug/1)
START MARKETING DATE: 2012-06-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-203_8f9023fb-e982-440a-a9ee-374c4bf3153b
PRODUCT NDC: 51808-203
APPLICATION NUMBER:

Other SINCALIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationSIncalide
Bracco Diagnostics Inc.KINEVAC